Since 1923, we have been focused on innovation and leadership in diabetes care. Today we have a broad portfolio of medicines.
Since the launch of our first pen needle in 1985, we have been committed to enhancing injection experience by putting technology in patient hands.
Access information on our products for rare bleeding disorders, growth hormone-related disorders, and women's health.
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
The link above used in conjunction with the FDA-approved product labeling may be used to determine U.S. patents associated with the corresponding U.S. marketed product.
A place to find different points of view
from inside Novo Nordisk and the communities we serve.
For Missy, a Novo Nordisk employee and registered nurse, the fight against diabetes is personal.
Learn about what we offer today and what’s coming in January 2020.
Donna was ashamed of living with obesity until she learned something about the disease that changed her life.
Read her story
Imagine you’re in your doctor’s office and you’ve just been told you have diabetes. Your life is changed forever.
A new study sheds light on diabetes costs beyond what you pay at the counter.
Pro cyclist Mandy Marquardt’s parents helped her find success on the track while living with diabetes.
A professional chef shares his nutrition know-how in New Jersey schools.
A Novo Nordisk employee on what makes him most proud: His family.
More than 115 kids took part in a fun-filled and informative day.
A Novo Nordisk employee shares her family’s story of fostering more than 100 kids and finding their adopted son.